ANN ARBOR, Mich.--(BUSINESS WIRE)--NanoBio Corporation today announced that Ali I. Fattom, Ph.D., has joined the company as Senior Vice President of Vaccine Research and Development. Dr. Fattom was previously Vice President of Research and Early Development at Nabi Biopharmaceuticals. In his new position, Dr. Fattom will draw upon his more than two decades of experience in vaccine research to lead NanoBio’s nanoemulsion-based intranasal and intramuscular vaccine programs.
